Latest articles:

In Certain Elderly Populations Regular Prostate-Specific Antigen Screening May Be Discontinued
Men aged 75-80 with prostate-specific antigen (PSA) levels less than 3 ng/ml may be able to discontinue their regular prostate cancer screenings, according to new research presented during the Annual Scientific Meeting of the American Urological Association (AUA). More: continued here
In Certain Elderly Populations Regular Prostate-Specific Antigen Screening May Be Discontinued...

Adjuvant Radiation Reduces Recurrence Of Prostate Cancer Following Surgery
Follow-up radiation after prostate cancer surgery significantly reduces men’s risk of suffering recurrence and spread and therefore should be offered to all high-risk patients, a study released May 20 suggests. More: continued here
Adjuvant Radiation Reduces Recurrence Of Prostate Cancer Following Surgery...

Praxis Launches Patient Recruitment Program For Women’s Health Medical Research Studies
Praxis, a company specializing in centralized patient recruitment for clinical research studies, is providing services to a rapidly growing biotechnology company for three national medical research studies. The studies explore a possible treatment for an important women’s health issue. After an in-depth feasibility analysis of all protocols, Praxis
Praxis Launches Patient Recruitment Program For Women’s Health Medical Research Studies...

Parallel Trade: Switzerland, The EU, And The US - International Society For Pharmacoeconomics And Outcomes Research
Parallel Trade of pharmaceutical products has become a common phenomenon in many parts of the world, with significant impact on the healthcare systems of the countries involved. An overview of the status quo of parallel trade of pharmaceuticals was performed to investigate its economic, political and legal
Parallel Trade: Switzerland, The EU, And The US - International Society For Pharmacoeconomics And Outcomes Research...

BioAlliance Acquired European Rights For Ondansetron Oral Spray To Complement Its Franchise In Cancer Supportive Care From NovaDel Pharma Inc.
BioAlliance Pharma SA (Paris:BIO) a specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, announced that it has acquired the European commercial rights to ondansetron Oral Spray (OS) from NovaDel Pharma Inc. (Amex: NVD). Ondansetron is the leading 5-HT3 antagonist largely used to
BioAlliance Acquired European Rights For Ondansetron Oral Spray To Complement Its Franchise In Cancer Supportive Care From NovaDel Pharma Inc....

New Guidance Reinforces Respect For Patient Choice, Say Doctors - UK
The new GMC1 guidance on patient consent issued yesterday marks a changing culture for patient choice and decision-making said the Chairman of the BMA’s Medical Ethics Committee (MEC), Dr Tony Calland.He commented:”The BMA contributed to the development of the GMC’s guidance because we believe that attitudes in society
New Guidance Reinforces Respect For Patient Choice, Say Doctors - UK...

BMA Support Your Surgery Campaign Goes Live, UK
Hard-hitting posters, patient information leaflets and stickers are being sent to GP surgeries as the BMA’s “Support Your Surgery” campaign goes live.The BMA is providing every GP practice in England with publicity material as part of its campaign to promote and defend NHS general practice. Family doctors are
BMA Support Your Surgery Campaign Goes Live, UK...

Study Looks At U.S.-Born, Foreign-Born Adults’ Use Of Medical Services
“Does Being an Immigrant Make a Difference in Seeking Physician Services?” Journal of Health Care for the Poor and Underserved: The study looked at how immigration status, acculturation and health care beliefs affect U.S-born and foreign-born adults’ use of medical services. More: continued here
Study Looks At U.S.-Born, Foreign-Born Adults’ Use Of Medical Services...

British Medical Journal Group Expands Into Europe And New Zealand
The BMJ Group’s mission to improve access to evidence based medicine for doctors around the world comes a step closer as a result of new agreements in Germany and New Zealand. The BMJ Group has signed a three year nationwide licensing agreement with the Bavarian State Library on
British Medical Journal Group Expands Into Europe And New Zealand...

Invasive Methods Unnecessary For Prostate Cancer Radiation Therapy Treatment Planning
Modern 3-D computed tomography (CT) is an effective method for locating the prostatic apex for radiation therapy treatment planning in prostate cancer patients because it eliminates the need for an invasive procedure and the related side effects, according to a study in the May 1 issue of the
Invasive Methods Unnecessary For Prostate Cancer Radiation Therapy Treatment Planning...